Hypertrophic Cardiomyopathy (CME)

Purpose/ Objective

 

CMR is a very useful diagnostic and prognostic tool in HCM. Several papers have shown the great advantage of CMR compared to other imaging modality and many techniques have been developed to improve the diagnostic and prognostic ability of CMR. This course will help to disseminate this knowledge with the ultimate aim to improve patient’s management. Following this activity learners will be able to understand the diagnostic features of HCM on CMR and how to better stratify prognosis with CMR.

 

Accreditation Statement

 

The Society for Cardiovascular Magnetic Resonance (SCMR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

Credit Designation Statement

 

The Society for Cardiovascular Magnetic Resonance (SCMR) designates this enduring material for a maximum of 0.05 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Instructions for Claiming CME

 

  • Attend the sessions in full for which credit is sought
  • Complete the post-activity evaluation
  • A certificate of completion will be available once the evaluation is submitted

 

Financial Disclosures

 

The planners and faculty for this activity did not have any relevant relationships to disclose, unless listed below:
 

Dr. Kramer received consulting fees from Abbott and research support from Bayer Healthcare, Biotelemetry and Sanofi/Regeneron.

Any resulting conflicts of interest were resolved prior to the start of the activity according to ACCME Criteria & Standards.

 

Disclosure of Commercial Support

 

SCMR received no funding to support this activity.

 

Bibliography

 

  • H Watkins NEJM 2011
  • Maron BJ et al Lancet 2013;381:242-255
  • Kramer CM et al Circulation 1994;90:186
  • Weng Z et al JACC CV Img 2016;9:1392-1402
  • Chan et al Circulation 2014;130:484
  • Dass S et al Circ CV Imaging 2012;5:726-733
  • Ho CY et al Circ CV Imaging 2013;6:415-422
  • Kramer CM et al Am Heart J 2015;170:223-30
  • Pozo E et al Heart 2014
  • McDiarmid AK Circ Cardiovasc Imaging 2016
  • Maestrini et al under review 2018
  • Teribel TA et al Circulation 2017;136:2519-2521
  • Swoboda PP et al JACC 2016;67:2189-2190
  • He et al Heart and Lung 2017;1-5
  • Ismail et al 2014 Heart 2014:100;1851-8
  • Chan et al Circulation 2014 Aug 5;130(6):484-495
  • Hussain et al Pediatr Cardiol 2015;36:970-8
  • Eur Heart J 2014;35:2739
  • JACC 2011;58:e212-260
  • Maron BJ et al Am J Cardiol 2015;116:757
  • Chan et al Circulation 2014;130:484
  • Wang et al J Am Coll Cardiol Img 2016;9:1392
  • Maron BJ, Maron MS JACC Card Imag 2016;9
Course Information
Course Date:
September 01, 2018
Hypertrophic cardiomyopathy
Athlete, hypertensive or hypertrophic heart?
CMR as first line diagnostic test in children at risk for HCM
Classic risk factors suffice in HCM patients to decide ICD therapy
Individual topic purchase: Selected
Accreditation Council For Continuing Medical Education
Total General Hours: 0.50
Products
On-Demand
SCMR Member Price:$10.00
Non-Member Price:$20.00